MDxHealth (MDXH) director-linked entity receives 10,000 share options at $0.76

Rhea-AI Filing Summary

MDxHealth SA director-associated entity receives new stock options. An entity linked to director Hilde Windels, Hilde Windels BV, was granted share options covering 10,000 ordinary shares at an exercise price of $0.76 per share. These options vest in full on the date of the annual general shareholders' meeting held in the calendar year after the grant year and expire on May 28, 2036. Following this grant, 10,000 share options are reported as held indirectly, and the reporting person disclaims beneficial ownership beyond any pecuniary interest in the securities held by Hilde Windels BV.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Windels Hilde

Role null

Type	Security	Shares	Price	Value
Grant/Award	Share Option	10,000	$0.00	--

Holdings After Transaction: Share Option — 10,000 shares (Indirect, By Hilde Windels BV)

Footnotes (1)

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted. Share Options held by Hilde Windels BV may be deemed to be beneficially owned by the Reporting Person as the Managing Director of Hilde Windels BV. The Reporting Person disclaims beneficial ownership of the securities held by Hilde Windels BV other than to the extent that she may have a pecuniary interest therein.

Key Figures

Options granted: 10,000 share options Exercise price: $0.76 per share Underlying shares: 10,000 ordinary shares +2 more

5 metrics

Options granted 10,000 share options Grant to Hilde Windels BV on June 1, 2026

Exercise price $0.76 per share Conversion or exercise price of the share options

Underlying shares 10,000 ordinary shares Each option exercisable into one ordinary share

Expiration date May 28, 2036 Option expiration for the granted share options

Post-grant derivative holdings 10,000 share options Total share options reported following the transaction

Key Terms

Share Option, Ordinary Shares, beneficially owned, pecuniary interest, +1 more

5 terms

Share Option financial

"Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76"

Ordinary Shares financial

"Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

beneficially owned financial

"Share Options held by Hilde Windels BV may be deemed to be beneficially owned by the Reporting Person as the Managing Director"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

pecuniary interest financial

"The Reporting Person disclaims beneficial ownership of the securities held by Hilde Windels BV other than to the extent that she may have a pecuniary interest therein"

annual general shareholders' meeting financial

"which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following"

A yearly meeting where a company’s shareholders and board of directors come together to review performance, vote on key issues (such as electing directors and approving auditors), and ask questions of management. Think of it like a town-hall or annual check-in where owners can influence how the company is run; outcomes can affect governance, dividend decisions and long-term strategy, all of which can influence the value and risks of an investor’s holdings.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Windels Hilde

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL BELGIUM 4040

(City) (State) (Zip)

BELGIUM

(Country)

2. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$0.76	06/01/2026		A		10,000		(1)	05/28/2036	Ordinary Shares	10,000	$0	10,000	I	By Hilde Windels BV(2)

Explanation of Responses:

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

2. Share Options held by Hilde Windels BV may be deemed to be beneficially owned by the Reporting Person as the Managing Director of Hilde Windels BV. The Reporting Person disclaims beneficial ownership of the securities held by Hilde Windels BV other than to the extent that she may have a pecuniary interest therein.

	/s/ Mark Busch, as attorney-in-fact for Hilde Windels	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MDXH director Hilde Windels report on this Form 4?

The filing reports a grant of share options for 10,000 ordinary shares to Hilde Windels BV, an entity associated with director Hilde Windels. The options are a compensation-related award, not an open-market share purchase or sale.

What are the key terms of the MDXH share options granted to Hilde Windels BV?

The share options cover 10,000 ordinary shares at an exercise price of $0.76 per share and expire on May 28, 2036. They represent a right to buy shares in the future at that fixed price.

When do the MDXH options granted to Hilde Windels BV vest?

The options vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year of grant. Vesting must occur before the options can be exercised for ordinary shares.

How many MDXH derivative securities does the entity linked to Hilde Windels hold after this transaction?

After this grant, 10,000 share options are reported as held indirectly by Hilde Windels BV. Each option is exercisable into one ordinary share, giving the entity potential future equity exposure if the options are exercised.

Does Hilde Windels personally own the MDXH options granted to Hilde Windels BV?

The options are held by Hilde Windels BV and may be deemed beneficially owned because Hilde Windels is its managing director. The reporting person expressly disclaims beneficial ownership beyond any pecuniary interest in the securities held by the entity.